Henrik Sorensen

Title: Henrik Sorensen: Innovator in Pharmaceutical Chemistry

Introduction

Henrik Sorensen is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes. His work has led to advancements in the preparation of complex chemical compounds.

Latest Patents

Henrik Sorensen holds a patent for a process titled "Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid." This invention provides a method for preparing substantially racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid by reacting an enriched enantiomer with a base in an inert solvent. This patent showcases his expertise in chemical synthesis and innovation.

Career Highlights

Henrik Sorensen is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on cutting-edge research and development projects. His contributions have been instrumental in advancing the company's pharmaceutical offerings.

Collaborations

Henrik has collaborated with esteemed colleagues such as Eva-Lotte Lindstedt-Alstermark and Kjell Andersson. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Henrik Sorensen is a distinguished inventor whose work in pharmaceutical chemistry has made a lasting impact. His innovative processes and collaborations continue to drive advancements in the industry.